By

Luke Timmerman

17
Oct
2018

Making it Easy to Share Biological Data: John Wilbanks on The Long Run Podcast

John Wilbanks is today’s guest on The Long Run podcast. He’s the chief commons officer of Sage Bionetworks. He’s also a senior fellow with FasterCures. Sage, for those unfamiliar, is a nonprofit biomedical research organization, founded in Seattle in 2009 by a couple of veterans of Merck. Co-founders Stephen Friend and Eric Schadt recognized that no single company’s R&D labs,...
Read More
22
Aug
2018

Building Startups With Pharma Needs in Mind: Thong Le on The Long Run Podcast

Today’s guest on The Long Run podcast is Thong Le. Le is the CEO of Accelerator Life Science Partners. It’s a venture capital backed operation that starts and nurtures biotech startups in Seattle, New York, San Diego and other places outside the main industry clusters of Boston and San Francisco. Accelerator, founded in 2003, currently invests out of a $63...
Read More
8
Aug
2018

The Antibiotic Opportunity? Spero’s Ankit Mahadevia on The Long Run Podcast

Today’s guest on The Long Run podcast is Ankit Mahadevia. Mahadevia is the CEO of Cambridge, Mass.-based Spero Therapeutics. It’s an antibiotic developer. Specifically, it’s focused on new strategies for fighting gram-negative bacterial infections that are increasingly resistant to our existing set of antibiotics. Despite persistent warnings from global health authorities about the rise of multi-drug resistant bugs, and the...
Read More
1 2 3 21